Two small-cap stocks that could have the potential for near-term upside are biotech Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Apple Inc. (NASDAQ:AAPL) supplier AU Optronics Corp (ADR) (NYSE:AUO)-- with the …
Cap Stocks
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock has been on quite a roller coaster ride in 2015. A few weeks ago, ARNA shares roared 76% higher in a single day after positive early-stage trials for an autoimmune …
The stock began the session at $64.73 and the volume stood at ... On Jun 2, 2016, Robert N. Karp (VP & President, ARNA) sold 27,573 shares at $55.12 per share price. CDK Global Inc. is a global provider both …
CDK Global Inc
At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA options chain for the new December 21st contracts and identified one put and one call contract of particular interest. The put contract at …
Arena Pharmaceuticals, Inc. (ARNA - Free Report) is scheduled to report third-quarter 2016 results on Nov 7, after the market closes. The company met earnings expectations last quarter. Over the four trailing quarters, it has …
ZACKS3mon
Earnings
Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All ARNA Stock Technical Studies are available in different time frames.
At the same time, VVUS closed at $5.78 with an only 2.48% increase. The comparison between the stock characteristics of both companies shows that they have a lot of similarities. The market value of ARNA is …
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. …
The stock presently has an average rating of Hold and a consensus target price of $3.08. Shares of Arena Pharmaceuticals (NASDAQ:ARNA) traded up 1.39% during mid-day trading on Monday, reaching $1.46. …
Arena Pharmaceuticals has been struggling to stay afloat as a company, especially with Belviq under performing in the obesity market. Thing are about to get worse because now it will have to go back to the drawing board. …
Stock